Vyvanse is a prescription stimulant medication used to treat ADHD in people ages 6 and older and moderate to severe binge eating disorder in adults. Its active ingredient, lisdexamfetamine, is a Schedule II controlled substance, placing it in the same regulatory category as other amphetamine-based medications. Unlike many stimulants, Vyvanse is designed as a prodrug, meaning it’s inactive when swallowed and only becomes active after your body processes it.
How Vyvanse Works in the Body
Vyvanse is pharmacologically inactive on its own. When you take a capsule, the medication passes through your stomach and into your bloodstream, where enzymes on the surface of red blood cells break it apart. This process splits the molecule into two pieces: dextroamphetamine (the active stimulant) and l-lysine (a naturally occurring amino acid your body already uses). Red blood cells have a high capacity for this conversion, so the process happens reliably even in people with lower red blood cell counts.
Dextroamphetamine increases the activity of two chemical messengers in the brain that regulate attention, impulse control, and motivation. In people with ADHD, these signaling systems tend to be underactive, which is why a stimulant can paradoxically improve focus and reduce restlessness. For binge eating disorder, the same brain pathways help reduce the compulsive urge to eat.
How Long It Takes to Work
Because the medication needs to be converted before it does anything, there’s a built-in delay. In clinical studies, children ages 6 to 12 showed improved attention within 1.5 hours of taking a dose, with effects lasting up to 13 hours. Adults with ADHD saw improvements starting at 2 hours, lasting up to 14 hours. That long duration is one of the main reasons Vyvanse is prescribed as a once-daily, morning-only medication. Most people don’t need a second dose later in the day.
Why the Prodrug Design Matters
The prodrug mechanism isn’t just a pharmacological curiosity. It was specifically engineered to reduce the potential for misuse. Traditional stimulants can be crushed and snorted or injected for a rapid, intense high. Vyvanse can’t deliver that effect because the drug has to pass through red blood cells to become active, regardless of how it enters the body. Crushing, snorting, or injecting it doesn’t speed up conversion. The DEA still classifies it as Schedule II due to its amphetamine content, but the design creates a ceiling on how quickly someone can feel its effects.
Dosing for ADHD and Binge Eating Disorder
For ADHD, the typical starting dose is 30 mg once daily in the morning. Your prescriber can increase it by 10 or 20 mg per week based on how well it’s working and how you tolerate it, up to a maximum of 70 mg per day. The goal is to find the lowest effective dose.
For binge eating disorder in adults, the starting dose is also 30 mg daily, but the target range is higher: 50 to 70 mg per day. The dose is increased in 20 mg increments at weekly intervals. The maximum remains 70 mg per day. Vyvanse is not approved for weight loss, only for reducing binge eating episodes.
How to Take It
You can swallow the capsule whole with water. If you have difficulty swallowing pills, you can open the capsule and dissolve the entire contents in a glass of water, then drink the solution immediately. Don’t save any of the mixture for later, and don’t split a single capsule into partial doses. The full capsule counts as one dose.
Common Side Effects
The most frequently reported side effects overlap between ADHD and binge eating disorder, though the pattern differs slightly. In ADHD clinical trials (across children, teens, and adults), the side effects occurring in at least 5% of patients and at twice the rate of placebo were:
- Decreased appetite and weight loss
- Insomnia
- Dry mouth
- Irritability
- Nausea, vomiting, or diarrhea
- Upper abdominal pain
- Dizziness
- Anxiety
In adults treated for binge eating disorder, the same core group appeared, with the addition of increased heart rate, constipation, and feeling jittery. Appetite suppression is nearly universal with stimulant medications and tends to be most noticeable in the first few weeks before the body adjusts somewhat.
Who Should Not Take Vyvanse
Vyvanse is not appropriate for everyone. It is contraindicated in people with serious cardiovascular conditions, including structural heart abnormalities, severe coronary artery disease, serious arrhythmias, uncontrolled high blood pressure, and advanced hardening of the arteries. People with narrow-angle glaucoma should also avoid it.
On the psychiatric side, Vyvanse can worsen agitation and anxiety, and it may trigger psychotic symptoms or manic episodes in people with bipolar disorder. A history of substance abuse is another significant concern, given the medication’s amphetamine component. If you have a personal or family history of tic disorders or Tourette’s syndrome, stimulant use requires careful consideration, as it can sometimes worsen tics.
Vyvanse should not be taken alongside a class of antidepressants called MAO inhibitors. A washout period of at least 14 days between the two is standard.
Generic Availability
Generic versions of Vyvanse (sold as lisdexamfetamine dimesylate) became available in 2023 after the brand’s patent exclusivity ended. Multiple manufacturers now produce it, including Alvogen, Apotex, Lannett, Rhodes, Sun Pharma, and Teva, among others. However, intermittent shortages have affected several manufacturers due to issues with the active ingredient supply. Some generic versions are on allocation or back order with no confirmed restock date. If your pharmacy can’t fill your prescription, calling around to other pharmacies or asking your prescriber about dose adjustments using available strengths can help bridge a gap.